Kara I. Cicero

Kara I. Cicero serves as an Academic Assistant Professor of Clinical Practice in the Department of Hematology and Oncology at the University of Washington School of Medicine and holds a concurrent Clinical Assistant Professor position at Fred Hutchinson Cancer Center. Her clinical work focuses on plasma cell disorders at the Fred Hutchinson Cancer Center - South Lake Union campus.

Education:

• M.D., Tulane University
• M.P.H., Tulane University
• Residency in Internal Medicine, Columbia University, New York Presbyterian
• Fellowship in Hematology/Oncology, Columbia University, New York Presbyterian

Dr. Cicero leads research advancing health equity in global oncology, specifically investigating disparities in plasma cell disorders including multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS). Her work examines racial and geographic disparities in disease prevalence and outcomes, with recent publications focusing on MGUS in Black South African populations and immune responses in transplant recipients.

Analysis of her publication record reveals consistent focus on hematologic malignancies, immunotherapy complications, and health disparities across high-impact journals including Cancer Epidemiology, Biomarkers & Prevention and The Oncologist. Her research bridges clinical oncology practice with epidemiological studies of underserved populations.

Professional Affiliations:

• Fred Hutchinson Cancer Center - Provider

Dr. Cicero's clinical expertise encompasses multiple myeloma, amyloidosis, plasma cell disorders, and Waldenström macroglobulinemia. While no formal student advising or grant information is publicly documented, her research collaborations span international institutions as evidenced by her South African population study. Her work at the Fred Hutchinson Cancer Center positions her within a major hematology research ecosystem focused on translational oncology.